DocDoc is an innovative business with considerable growth potential plus early mover/competitive advantages. We believe it is disruptive in ways that benefit its key industry stakeholders: patients, medical practitioners and insurers. We recently met DocDoc’s CEO Cole Sirucek to discuss the company’s business model and growth strategy and regard Singapore-based DocDoc as a prime example of the potential of ADAM’s investment template.
19 Dec 2019
Just what the doctor ordered
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Just what the doctor ordered
Jade Road Investments Limited (JADE:LON) | 1.4 0 0.0% | Mkt Cap: 4.89m
- Published:
19 Dec 2019 -
Author:
Roger Leboff -
Pages:
6
DocDoc is an innovative business with considerable growth potential plus early mover/competitive advantages. We believe it is disruptive in ways that benefit its key industry stakeholders: patients, medical practitioners and insurers. We recently met DocDoc’s CEO Cole Sirucek to discuss the company’s business model and growth strategy and regard Singapore-based DocDoc as a prime example of the potential of ADAM’s investment template.